State Board of Administration of Florida Retirement System’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,630
Closed -$72.9K 2242
2024
Q1
$72.9K Buy
+12,630
New +$33.7K ﹤0.01% 2100
2023
Q3
Sell
-12,630
Closed -$79.6K 2368
2023
Q2
$79.6K Hold
12,630
﹤0.01% 2321
2023
Q1
$72.9K Hold
12,630
﹤0.01% 2190
2022
Q4
$130K Hold
12,630
﹤0.01% 2157
2022
Q3
$211K Hold
12,630
﹤0.01% 2036
2022
Q2
$177K Buy
+12,630
New +$171K ﹤0.01% 2144

Other funds holding DSGN

State Board of Administration of Florida Retirement System's DSGN Position: Q2 2024 in Review

State Board of Administration of Florida Retirement System sold out of Design Therapeutics (DSGN) in Q2 2024, closing a stake of 12,630 shares — an estimated $72.9K sold.

State Board of Administration of Florida Retirement System first reported a position in DSGN in Q2 2022 and held it in 6 quarters. The position peaked at $211K in Q3 2022. 95 funds tracked by Wall St. Rank hold DSGN as of Q2 2024.

  • State Board of Administration of Florida Retirement System reported no remaining Design Therapeutics position as of Q2 2024 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 12,630 Design Therapeutics shares in Q2 2024, an estimated $72.9K.
  • State Board of Administration of Florida Retirement System first reported a position in Design Therapeutics in Q2 2022 and held it in 6 quarters.
  • State Board of Administration of Florida Retirement System's Design Therapeutics position peaked at $211K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.